Cargando…
The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The ai...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963342/ https://www.ncbi.nlm.nih.gov/pubmed/29896410 http://dx.doi.org/10.14336/AD.2017.0429 |
_version_ | 1783325033116991488 |
---|---|
author | Takeuchi, Hidemi Uchida, Haruhito A. Kakio, Yuki Okuyama, Yuka Okuyama, Michihiro Umebayashi, Ryoko Wada, Kentaro Sugiyama, Hitoshi Sugimoto, Ken Rakugi, Hiromi Wada, Jun |
author_facet | Takeuchi, Hidemi Uchida, Haruhito A. Kakio, Yuki Okuyama, Yuka Okuyama, Michihiro Umebayashi, Ryoko Wada, Kentaro Sugiyama, Hitoshi Sugimoto, Ken Rakugi, Hiromi Wada, Jun |
author_sort | Takeuchi, Hidemi |
collection | PubMed |
description | The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The aim of this study was to identify the prevalence and predictors of frailty in Japanese HD patients. This study was a multicenter, cross-sectional and observational investigation conducted at 6 institutions. To evaluate frailty, the modified Fried’s frailty phenotype adjusted for Japanese as the self-reported questionnaire was used. Of the 542 patients visiting each institution, 388 were enrolled in this study. In total, 26.0% of participants were categorized as not-frailty, 52.6% as pre-frailty and 21.4% as frailty. The prevalence of frailty increased steadily with age and was more prevalent in females than in males and the subjects with frailty received polypharmacy. A multivariate logistic regression analysis revealed that the factors independently associated with frailty were the following: female gender (odds ratio [OR] = 3.661, 95% confidence interval [CI] 1.398-9.588), age (OR = 1.065, 95% CI 1.014-1.119), age ≥ 75 years old (OR = 4.892, 95% CI 1.715-13.955), body mass index (BMI) < 18.5 (OR = 0.110, 95% CI 0.0293-0.416), number of medications being taken (OR = 1.351, 95% CI 1.163-1.570), diabetes mellitus (DM) (OR = 2.765, 95% CI 1.081-7.071) and MNA-SF ≤ 11 (OR = 7.405, 95% CI 2.732-20.072). Frailty was associated with the accumulation of risk factors. The prevalence of frailty in Japanese patients with HD was relatively lower than that previously reported in Western developed countries; however, it was extremely high compared to the general population regardless of age. Our findings suggest that frailty might be associated with an increase in the prevalence of adverse health outcomes in patients with HD. |
format | Online Article Text |
id | pubmed-5963342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | JKL International LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59633422018-06-12 The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients Takeuchi, Hidemi Uchida, Haruhito A. Kakio, Yuki Okuyama, Yuka Okuyama, Michihiro Umebayashi, Ryoko Wada, Kentaro Sugiyama, Hitoshi Sugimoto, Ken Rakugi, Hiromi Wada, Jun Aging Dis Orginal Article The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The aim of this study was to identify the prevalence and predictors of frailty in Japanese HD patients. This study was a multicenter, cross-sectional and observational investigation conducted at 6 institutions. To evaluate frailty, the modified Fried’s frailty phenotype adjusted for Japanese as the self-reported questionnaire was used. Of the 542 patients visiting each institution, 388 were enrolled in this study. In total, 26.0% of participants were categorized as not-frailty, 52.6% as pre-frailty and 21.4% as frailty. The prevalence of frailty increased steadily with age and was more prevalent in females than in males and the subjects with frailty received polypharmacy. A multivariate logistic regression analysis revealed that the factors independently associated with frailty were the following: female gender (odds ratio [OR] = 3.661, 95% confidence interval [CI] 1.398-9.588), age (OR = 1.065, 95% CI 1.014-1.119), age ≥ 75 years old (OR = 4.892, 95% CI 1.715-13.955), body mass index (BMI) < 18.5 (OR = 0.110, 95% CI 0.0293-0.416), number of medications being taken (OR = 1.351, 95% CI 1.163-1.570), diabetes mellitus (DM) (OR = 2.765, 95% CI 1.081-7.071) and MNA-SF ≤ 11 (OR = 7.405, 95% CI 2.732-20.072). Frailty was associated with the accumulation of risk factors. The prevalence of frailty in Japanese patients with HD was relatively lower than that previously reported in Western developed countries; however, it was extremely high compared to the general population regardless of age. Our findings suggest that frailty might be associated with an increase in the prevalence of adverse health outcomes in patients with HD. JKL International LLC 2018-04-01 /pmc/articles/PMC5963342/ /pubmed/29896410 http://dx.doi.org/10.14336/AD.2017.0429 Text en Copyright: © 2018 Takeuchi et al. http://creativecommons.org/licenses/by/2.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Orginal Article Takeuchi, Hidemi Uchida, Haruhito A. Kakio, Yuki Okuyama, Yuka Okuyama, Michihiro Umebayashi, Ryoko Wada, Kentaro Sugiyama, Hitoshi Sugimoto, Ken Rakugi, Hiromi Wada, Jun The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients |
title | The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients |
title_full | The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients |
title_fullStr | The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients |
title_full_unstemmed | The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients |
title_short | The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients |
title_sort | prevalence of frailty and its associated factors in japanese hemodialysis patients |
topic | Orginal Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963342/ https://www.ncbi.nlm.nih.gov/pubmed/29896410 http://dx.doi.org/10.14336/AD.2017.0429 |
work_keys_str_mv | AT takeuchihidemi theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT uchidaharuhitoa theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT kakioyuki theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT okuyamayuka theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT okuyamamichihiro theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT umebayashiryoko theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT wadakentaro theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT sugiyamahitoshi theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT sugimotoken theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT rakugihiromi theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT wadajun theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT takeuchihidemi prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT uchidaharuhitoa prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT kakioyuki prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT okuyamayuka prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT okuyamamichihiro prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT umebayashiryoko prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT wadakentaro prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT sugiyamahitoshi prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT sugimotoken prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT rakugihiromi prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients AT wadajun prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients |